449 related articles for article (PubMed ID: 15606555)
1. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
[TBL] [Abstract][Full Text] [Related]
2. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
Morelli VM; de Visser MC; van Tilburg NH; Vos HL; Eikenboom JC; Rosendaal FR; Bertina RM
Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014
[TBL] [Abstract][Full Text] [Related]
3. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
[TBL] [Abstract][Full Text] [Related]
4. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
[TBL] [Abstract][Full Text] [Related]
5. Genotype at the secretor blood group locus is a determinant of plasma von Willebrand factor level.
O'Donnell J; Boulton FE; Manning RA; Laffan MA
Br J Haematol; 2002 Feb; 116(2):350-6. PubMed ID: 11841438
[TBL] [Abstract][Full Text] [Related]
6. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
[TBL] [Abstract][Full Text] [Related]
7. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism.
Tirado I; Mateo J; Soria JM; Oliver A; Martínez-Sánchez E; Vallvé C; Borrell M; Urrutia T; Fontcuberta J
Thromb Haemost; 2005 Mar; 93(3):468-74. PubMed ID: 15735796
[TBL] [Abstract][Full Text] [Related]
8. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?
Jenkins PV; O'Donnell JS
Transfusion; 2006 Oct; 46(10):1836-44. PubMed ID: 17002642
[TBL] [Abstract][Full Text] [Related]
9. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort.
Morange PE; Tregouet DA; Frere C; Saut N; Pellegrina L; Alessi MC; Visvikis S; Tiret L; Juhan-Vague I
Br J Haematol; 2005 Jan; 128(1):91-9. PubMed ID: 15606554
[TBL] [Abstract][Full Text] [Related]
10. ABO blood group and von Willebrand factor levels partially explained the incomplete penetrance of congenital thrombophilia.
Cohen W; Castelli C; Alessi MC; Aillaud MF; Bouvet S; Saut N; Brunet D; Barthet MC; Tregouet DA; Lavigne G; Morange PE
Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):2021-8. PubMed ID: 22628432
[TBL] [Abstract][Full Text] [Related]
11. Low density lipoprotein receptor-related protein polymorphisms are not risk factors for venous thromboembolism.
Mello TB; Siqueira LH; Montavão SA; Ozello MC; Annichino-Bizzacchi JM
Thromb Res; 2008; 121(5):625-9. PubMed ID: 17889283
[TBL] [Abstract][Full Text] [Related]
12. Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women.
Ay C; Thom K; Abu-Hamdeh F; Horvath B; Quehenberger P; Male C; Mannhalter C; Pabinger I
Haemophilia; 2010 Jan; 16(1):111-7. PubMed ID: 19758307
[TBL] [Abstract][Full Text] [Related]
13. The effect of ABO blood group on von Willebrand response to exercise.
Ribeiro JL; Salton GD; Bandinelli E; Oliveira AR; Roisenberg I
Clin Appl Thromb Hemost; 2008 Oct; 14(4):454-8. PubMed ID: 18160595
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in exons 6 and 7 of the ABO locus and their association with venous thrombosis in young Brazilian patients.
Paiva SG; Sabino AP; Carvalho MG; Ribeiro DD; Gomes KB; Santos MS; Oliveira MS; Lages GG; Dusse LM; Fernandes AP
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):122-8. PubMed ID: 19786939
[TBL] [Abstract][Full Text] [Related]
15. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
16. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
[TBL] [Abstract][Full Text] [Related]
17. Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism.
Shovlin CL; Sulaiman NL; Govani FS; Jackson JE; Begbie ME
Thromb Haemost; 2007 Nov; 98(5):1031-9. PubMed ID: 18000608
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction.
O'Donnell J; Tuddenham EG; Manning R; Kemball-Cook G; Johnson D; Laffan M
Thromb Haemost; 1997 May; 77(5):825-8. PubMed ID: 9184386
[TBL] [Abstract][Full Text] [Related]
19. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.
Albánez S; Ogiwara K; Michels A; Hopman W; Grabell J; James P; Lillicrap D
J Thromb Haemost; 2016 May; 14(5):953-63. PubMed ID: 26875505
[TBL] [Abstract][Full Text] [Related]
20. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
